W2N-57783-14527
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 800 / CO
- Registered
- 2021-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Registered in v-safe
-
2021-01-06
Dose 1 — Moderna
- 2021-01-06
-
2021-01-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-22
- 2021-01-27
-
2021-02-03
Dose 2 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
-
2021-02-10
Health check-in — day 7, dose 2Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to workAdult check-in
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Sore throat, congestion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — day 21, dose 2MedDRA: Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Congestion, sore throat.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-05
- 2021-08-04
-
2021-10-22
Dose 3 — Moderna
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-13
- 2021-11-19
- 2021-11-28
- 2021-12-03
- 2022-01-21
- 2022-04-22
-
2022-09-27
Dose 4 — Pfizer-BioNTech
- 2022-09-27
-
2022-09-28
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-09-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2022-10-02
- 2022-10-04
- 2022-10-11
- 2022-10-19
- 2022-10-25
- 2022-11-01
- 2022-11-08
-
2022-12-27
Survey response — 3 months, dose 4MedDRA: Laryngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: LaryngitisMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Moderna | |
| 2 | 2021-02-03 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-09-27 | Pfizer-BioNTech | No |
Free text
Release 4 — day 14, dose 2
Symptoms: Sore throat, congestion.
Release 4 — day 21, dose 2
Symptoms: Congestion, sore throat.
Release 12 — 3 months, dose 4
Symptoms: Laryngitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Laryngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release